Varicella
📧 Sign up to get email alerts when something new happens for Varicella.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy [Phase 1]
Phase 1 clinical trial evaluating safety, pharmacokinetics and pharmacodynamics of TNM005 in healthy adults; Varicella is the listed conditi…
-
FDA approval · 2024-06-25FDA Approved: ACYCLOVIR — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for a generic acyclovir product by Fresenius Kabi USA, LLC. This allows marketing of the generic antiv…
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old [Phase 3]
Phase 3 trial update evaluating safety and immunogenicity of a live attenuated varicella vaccine in healthy individuals aged 13 and older.
-
FDA approval · 2024-01-08FDA Approved: ACYCLOVIR — Original Application (Slate Run Pharmaceuticals, LLC)
The FDA approved the original ANDA for acyclovir from Slate Run Pharmaceuticals, LLC, authorizing a generic acyclovir product. This marks re…
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old [Phase 3]
A Phase 3 trial update assessing safety and immunogenicity of a live attenuated varicella vaccine in healthy individuals aged 13 and older h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-11-21FDA Approved: ACYCLOVIR — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved the original application for acyclovir by Alembic Pharmaceuticals Inc., making a generic version of the antiviral available.
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines [Phase 4]
Phase 4 trial updating immunogenicity and safety of an inactivated SARS-CoV-2 vaccine when coadministered with two attenuated vaccines, focu…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine [Phase 3]
A Phase III clinical trial evaluating the efficacy and safety of a live attenuated varicella vaccine for varicella, currently active but not…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of Age [Phase 3]
A Phase 3 clinical trial update evaluating lot-to-lot consistency of a live attenuated varicella vaccine in healthy children aged 1–12 years…
-
FDA approval · 2023-05-11FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for valacyclovir hydrochloride (generic valacyclovir) from Mylan Pharmaceuticals Inc., under AND…
-
FDA approval · 2023-05-08FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for Valacyclovir hydrochloride from Aurobindo Pharma Limited. The approval confirms continued market…
-
FDA approval · 2023-03-23FDA Approved: VALACYCLOVIR — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
FDA approved a supplemental application for valacyclovir from Sun Pharmaceutical Industries, a generic antiviral indicated for herpes infect…
-
FDA approval · 2023-03-09FDA Approved: ACYCLOVIR SUSPENSION — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved ACYCLOVIR SUSPENSION under Original Application for a generic acyclovir suspension by Novadoz Pharmaceuticals LLC.
-
FDA approval · 2023-02-28FDA Approved: ACYCLOVIR — Original Application (Viona Pharmaceuticals Inc)
The FDA approved an Original Application (ANDA) for acyclovir by Viona Pharmaceuticals Inc, establishing a generic version of the antiviral …
-
FDA approval · 2023-02-23FDA Approved: VALACYCLOVIR — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for Valacyclovir by Quallent Pharmaceuticals Health LLC under ANDA203047, indicating a regulatory up…
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Anhui Province [Phase 4]
Phase 4 trial update on a live attenuated varicella vaccine assessing protective effect, safety, and immunogenicity in Anhui Province.
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster Virus [Phase 4]
Phase 4 trial update evaluating immunogenicity, safety, and protective effect of a live attenuated varicella vaccine with antibody level and…
-
CLINICAL_TRIALS trial_result · 2022-09-02Clinical Trial Update: A Study of Combined Immunization With Live Attenuated Varicella Vaccine and Inactivated Hepatitis A Vaccine [Phase 4]
Phase 4 trial update on combined immunization with live attenuated varicella vaccine and inactivated hepatitis A vaccine; study completed.
-
FDA approval · 2022-08-18FDA Approved: ACYCLOVIR — Original Application (Advagen Pharma Limited)
FDA approves the original ANDA for acyclovir from Advagen Pharma Limited.
-
FDA approval · 2022-07-01FDA Approved: ACYCLOVIR — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original ANDA for generic acyclovir, enabling brand-generic competition for this antiviral. The approva…
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization [Phase 3]
Phase 3 open-label trial assessing immunity persistence after primary varicella vaccination and safety/immunogenicity after booster vaccinat…
-
FDA approval · 2021-11-15FDA Approved: ACYCLOVIR — Original Application (Solco Healthcare US, LLC)
FDA approved the original application for acyclovir from Solco Healthcare US, LLC (oral generic).
-
FDA approval · 2021-11-01FDA Approved: ACYCLOVIR — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's supplemental application for acyclovir.
-
CLINICAL_TRIALS trial_result · 2021-10-18Clinical Trial Update: Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011) [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of concomitant MMR rHA and VARIVAX given intramuscularly versus subcutaneously.
-
FDA approval · 2021-07-16FDA Approved: AVACLYR — Supplemental Application (Fera Pharmaceuticals, LLC)
The FDA approved a supplemental application for AVACLYR (acyclovir) from Fera Pharmaceuticals, LLC.